[Federal Register Volume 78, Number 165 (Monday, August 26, 2013)]
[Notices]
[Page 52802]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-20761]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Morton Grove Pharmaceuticals

    By Notice dated March 12, 2013, and published in the Federal 
Register on March 20, 2013, 78 FR 17231, Morton Grove Pharmaceuticals, 
6451 Main Street, Morton Grove, Illinois 60053-2633, made application 
by renewal to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of Gamma Hydroxybutyric Acid (2010), 
a basic class of controlled substance listed in schedule I.
    The company plans to manufacture the listed controlled substance 
for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a), and determined that the registration 
of Morton Grove Pharmaceuticals to manufacture the listed basic class 
of controlled substance is consistent with the public interest at this 
time. DEA has investigated Morton Grove Pharmaceuticals to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems; verification of the company's compliance 
with state and local laws; and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic class of controlled substance listed.

    Dated: August 15, 2013.
 Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-20761 Filed 8-23-13; 8:45 am]
BILLING CODE 4410-09-P